RRC ID 19649
著者 Konishi H, Kikuchi S, Ochiai T, Ikoma H, Kubota T, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Sonoyama T, Kokuba Y, Sasaki H, Matsui T, Otsuji E.
タイトル Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice.
ジャーナル Anticancer Res
Abstract Peritoneal dissemination of gastric cancer is a refractory disease. This paper focuses on the efficacy of actin-binding marine macrolide latrunculin A, which quickly inhibits actin polymerization and disrupts the function of the actin cytoskeleton. The effects of latrunculin A on cell viability in vitro were evaluated by treatment of MKN45 or NUGC-4 cell cultures. An in vitro viability assay demonstrated an anticancer effect of latrunculin A in a dose-dependent manner. Latrunculin A induced acute cell injury and programmed cell death through activating the caspase-3/7 pathway. In vivo, MKN45 or NUGC-4 cells were intraperitoneally inoculated into nude mice, as a model of peritoneal dissemination. Intraperitoneal (i.p.) injection of latrunculin A significantly improved survival rate in mice without any major side-effects. Data indicated that latrunculin A has strong anticancer effects, and it may be a new candidate i.p. drug against peritoneal dissemination of gastric cancer in humans.
巻・号 29(6)
ページ 2091-7
公開日 2009-6-1
PII 29/6/2091
PMID 19528469
MeSH Adenocarcinoma / drug therapy Adenocarcinoma / secondary Animals Apoptosis / drug effects Bridged Bicyclo Compounds, Heterocyclic / pharmacology* Carcinoma, Signet Ring Cell / drug therapy Carcinoma, Signet Ring Cell / secondary Caspases / metabolism Cell Line, Tumor Humans Injections, Intraperitoneal Male Marine Toxins / pharmacology* Mice Mice, Inbred BALB C Mice, Nude Peritoneal Neoplasms / drug therapy* Peritoneal Neoplasms / secondary* Stomach Neoplasms / drug therapy* Stomach Neoplasms / pathology Thiazolidines / pharmacology* Xenograft Model Antitumor Assays
IF 1.994
引用数 31
WOS 分野 ONCOLOGY
リソース情報
ヒト・動物細胞 NUGC-4(RCB1939)